This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Complications » Heart Disease

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

High-Heat-Treated Foods Promotes Risk Factors for Diabetes and Cardiovascular Diseases

Posted: Sunday, April 04, 2010

The modern Western lifestyle is characterized by the consumption of high-heat-treated foods because of their characteristic taste and flavor. However, it has been shown that treating food at high temperatures can generate potentially harmful compounds that promote inflammation and cardiovascular disease in subjects with diabetes.

Drugs Don't Reduce Heart Problems for Diabetes Patients

Posted: Sunday, March 28, 2010

Key results from a landmark federal study are in and the results are disappointing for diabetes patients: adding drugs to drive blood pressure and blood-fats lower than current targets did not prevent heart problems, and in some cases caused harmful side effects.

Tight Blood Pressure Control Not Supported in Patients with Diabetes and Coronary Artery Disease

Posted: Sunday, March 28, 2010

Current blood pressure (BP) guidelines for individuals with diabetes (systolic BP [SBP] <130 mm Hg) based on the notion that lower is better were not supported by results of the International Verapamil SR-Trandolapril (INVEST) study.

Potential New Anti-Inflammatory Drug for Type 2 Diabetes

Posted: Sunday, March 28, 2010

An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.

Postprandial Hyperglycemia and Increased Cardiovascular Risk

Posted: Sunday, March 21, 2010

Hyperglycemia is a major risk factor for both the microvascular and macrovascular complications in patients with Type 2 diabetes. This review summarizes the cardiovascular results of large outcomes trials in diabetes and presents new evidence on the role of hyperglycemia, with particular emphasis on postprandial hyperglycemia, in adverse cardiovascular outcomes in patients with Type 2 diabetes.

High Cholesterol, Diabetes Lead Drug Spending for the Elderly

Posted: Sunday, March 21, 2010

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 -- about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers.

A1c's Over Five Percent Increase Risk for Stroke

Posted: Sunday, March 14, 2010

Glycated hemoglobin (HbA1c), even at levels considered in the "normal" range, emerged as an independently significant predictor of heart-disease events, stroke, and death over more than a decade in an analysis from the Atherosclerosis Risk in Communities (ARIC) study. The risks of incident diabetes, coronary heart disease events, and death were significantly increased for all HbA1c values higher than the reference range of 5.0% to <5.5%.

Different Oral Antidiabetics Associated with Different Adverse Outcomes?

Posted: Sunday, March 07, 2010

Risk of cardiovascular disease and all-cause mortality among patients with Type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Dialysis Patients: Fatigue May Predict Heart Attack

Posted: Sunday, March 07, 2010

For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a new study.

FDA Reviewers Urge Pulling Rosiglitazone

Posted: Sunday, February 28, 2010

Two FDA reviewers have recommended that the diabetes drug rosiglitazone (Avandia) be pulled from the market because of its link to major cardiac events.